Cargando…

Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits

PURPOSE OF REVIEW: The incidence of type 1 diabetes (T1D) is rising in all age groups. T1D is associated with chronic microvascular and macrovascular complications but improving glycemic trends can delay the onset and slow the progression of these complications. Utilization of technological devices...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pauley, Meghan E., Tommerdahl, Kalie L., Snell-Bergeon, Janet K., Forlenza, Gregory P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Diabetes and Cardiovascular Disease (D Bruemmer, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589770/ https://www.ncbi.nlm.nih.gov/pubmed/36279036 http://dx.doi.org/10.1007/s11886-022-01799-x

Ejemplares similares

Diabetes and Cardiovascular Complications: The Epidemics Continue
por: López-Díez, Raquel, et al.
Publicado: (2021)

Comprehensive Care Models for Cardiometabolic Disease
por: Reiter-Brennan, Cara, et al.
Publicado: (2021)

Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
por: Umpierrez, Guillermo E., et al.
Publicado: (2018)

The Insulin Treatment Satisfaction Questionnaire and Assessment of Satisfaction with a Latest-generation Insulin Pump
por: Bromba, Michael, et al.
Publicado: (2015)

Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear
por: Yeh, Tiffany, et al.
Publicado: (2021)

Barriers to Uptake of Insulin Technologies and Novel Solutions
por: Pauley, Meghan E, et al.
Publicado: (2021)

SUN-151 Improved Glycemic Control with Automated Insulin Pump (AIP) Technology
por: Amole, Morolake, et al.
Publicado: (2019)

Insulin Edema With Use of U-500 Regular Insulin in a Hybrid Closed-Loop Insulin Pump
por: Vasigh, Mostafa, et al.
Publicado: (2020)

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
por: Martin, Christopher T., et al.
Publicado: (2019)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes
por: Nallicheri, Armaan, et al.
Publicado: (2022)

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems
por: Marks, Brynn E., et al.
Publicado: (2021)

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)

Associations of Dietary Antioxidants with Glycated Hemoglobin and Insulin Sensitivity in Adults with and without Type 1 Diabetes
por: Basu, Arpita, et al.
Publicado: (2022)

cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data
por: Vigers, Tim, et al.
Publicado: (2019)

Analytical and clinical challenges in a patient with concurrent type 1 diabetes, subcutaneous insulin resistance and insulin autoimmune syndrome
por: Jassam, N, et al.
Publicado: (2014)

PSUN281 Safety and Efficacy of Virtual Insulin Pump Initiation in Adults with Diabetes
por: Everett, Estelle, et al.
Publicado: (2022)

FRI654 Concentrated Regular U-500 Insulin In An Automated Insulin Delivery System: A Case Report
por: Aurora, John, et al.
Publicado: (2023)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes
por: Naegeli, A N, et al.
Publicado: (2010)

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
por: Bublik, Evgeniya, et al.
Publicado: (2022)

Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care
por: Avari, Parizad, et al.
Publicado: (2022)

Novel Bluetooth-Enabled Tubeless Insulin Pump: A User Experience Design Approach for a Connected Digital Diabetes Management Platform
por: Pillalamarri, Sandhya S., et al.
Publicado: (2018)

A Comparative Pulse Accuracy Study of Two Commercially Available Patch Insulin Infusion Pumps
por: Bowen, Jenna L, et al.
Publicado: (2016)

ODP199 Full Implementation of Automated Self-Adjusting Subcutaneous Insulin Algorithm
por: Mehta, Paras, et al.
Publicado: (2022)

The Psychological Implications of Automated Insulin Delivery Systems in Type 1 Diabetes Care
por: Nefs, Giesje
Publicado: (2022)

Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy
por: Landgraf, Wolfgang, et al.
Publicado: (2016)

Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes: The CACTI Study
por: Schauer, Irene E., et al.
Publicado: (2011)

Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: protocol for a randomised controlled trial
por: Schultz, Anders Nikolai Ørsted, et al.
Publicado: (2022)

Insulin Therapy and Cancer
por: Home, Philip
Publicado: (2013)

Insulin Pump in Difficult to Control Type 2 Diabetes: A Single Center, Five Years' Experience
por: Singh, Priyamvada, et al.
Publicado: (2018)

OR28-2 Assessing Longitudinal Disparities in Insulin Pump Use Among Youth with Type 1 Diabetes
por: Bell, Ronny Antonio, et al.
Publicado: (2022)

SAT103 Strategies To Enhance Insulin Pump Backup Plan Delivery: A Quality Improvement Project
por: Krutilova, Petra, et al.
Publicado: (2023)

A comparison of the clinical courses of type 2 diabetic patients whose basal insulin preparation was replaced from insulin glargine 100 units/mL to insulin glargine biosimilar or 300 units/mL: a propensity score-matched observation study
por: Ito, Hiroyuki, et al.
Publicado: (2018)

Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials
por: Lim, Beng Leong, et al.
Publicado: (2023)

Shifting the Disease Management Paradigm From Glucose: What are the pros?
por: Stirban, Alin, et al.
Publicado: (2009)

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
por: Versari, Daniele, et al.
Publicado: (2009)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
por: Bianchi, Cristina, et al.
Publicado: (2009)

Glucose Control and Cardiovascular Disease: Is it important? No
por: Conget, Ignacio, et al.
Publicado: (2009)

A Summary of the ADVANCE Trial
por: Heller, Simon R.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_cm35epr45breos0g5rrchaci7l